Article
An integrative network medicine approach identifies Erlotinib as a repurposed therapeutic candidate for obesity
2026-08-26
Abstract excerpt
<title>Abstract</title> <p> Background Obesity is a complex metabolic disorder characterized by adipose tissue dysfunction, chronic inflammation, and lipid metabolism disorders. Current anti-obesity therapies remain limited by efficacy and safety concerns. Drug repurposing offers an efficient strategy for therapeutic discovery, but cell-type-specific approaches are still lacking. Methods We developed a cell-ty...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 16c79adb-d196-5f2c-b35a-5588924749e7
- DOI
- 10.21203/rs.3.rs-10469287/v1
